Vasodilator Response to Nifedipine in Human Coronary Arteries with Endothelial Dysfunction
- 1 February 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 39 (2) , 172-180
- https://doi.org/10.1097/00005344-200202000-00003
Abstract
The purpose of the current study was to evaluate nifedipine-induced epicardial and microvascular response in human coronary arteries with and without endothelial dysfunction and intimal thickening. The investigation was performed in 70 patients 5 ± 5 months after heart transplantation. Coronary vasomotor function was determined with intracoronary acetylcholine adenosine, and nifedipine, respectively. Intravascular ultrasound was used to detect significant intimal hyperplasia. In a subgroup (n = 38), coronary sinus and aortic endothelin concentrations were determined. Epicardial dilation to nifedipine was significantly enhanced in coronary arteries with endothelial dysfunction (p = 0.04), whereas adenosine-induced epicardial dilation was attenuated in segments with endothelial dysfunction (p = 0.002). In cases of intimal hyperplasia, nifedipine-mediated distal vasodilation was increased compared with normal segments (p = 0.03). Coronary flow index nifedipine was enhanced in patients with microvascular endothelial dysfunction (p = 0.037). A trend was observed between high endothelin plasma levels in the coronary sinus and an increased microvasodilation to nifedipine (p = 0.04). The study shows that epicardial and microvascular dilation to nifedipine is enhanced in the setting of coronary endothelial dysfunction, suggesting supersensitive dilator response. The association between microvascular response to nifedipine and endothelin levels in the coronary sinus needs further clarification.Keywords
This publication has 25 references indexed in Scilit:
- Restoration of Nitric Oxide Availability After Calcium Antagonist Treatment in Essential HypertensionHypertension, 2001
- Nifedipine Increases Endothelial Nitric Oxide Bioavailability by Antioxidative MechanismsHypertension, 2001
- Nitroglycerin-induced coronary vasodilation is not enhanced in patients with impaired endothelium-dependent dilationJournal of the American College of Cardiology, 1996
- Normalization of Abnormal Coronary Vasomotion by Calcium Antagonists in Patients With HypertensionCirculation, 1996
- Experimental Vasoprotection by Calcium Antagonists Against Calcium-Mediated Arteriosclerotic AlterationsJournal of Cardiovascular Pharmacology, 1994
- Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells. Correlation of protection with preservation of glutathione levels.Circulation Research, 1992
- Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo.Proceedings of the National Academy of Sciences, 1991
- Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor.Circulation, 1991
- Retardation of angiographic progression of coronary artery disease by nifedipineThe Lancet, 1990
- Modulation of the Vasodilator Action of SIN-1 by the EndotheliumJournal of Cardiovascular Pharmacology, 1989